Femoral Trial Market to Register CAGR XX% Growth in Revenue During the Forecast Period 2018 - 2026

07/apr/2020 12:47:21 persistencemarketresearch Contatta l'autore

Questo comunicato è stato pubblicato più di 30 giorni fa. Le informazioni su questa pagina potrebbero non essere attendibili.

A femoral trial is the curved convex head at the end of the thigh bone that fits into the socket of the hip. Artificial femoral trials are used to replace the damaged head or loss of trial femoral heads in soft tissues after hip replacement surgery.

The global femoral trial market is primarily driven by the growing number of orthopedic surgeries owing to an increases in risk factors such as obesity, sedentary lifestyle, malabsorption, trauma, and poor diet, among others.

The growing prevalence of diseases, such as osteoarthritis and early menopause, affects structure and bone density, which increases the propensity of fractures. According to Centers for Disease Control and Prevention, osteoarthritis affects over 30 million adults in the U.S.

To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/24079

Technological advancements in femoral trial technology, such as the development of advanced bearing materials that include antioxidant-infused polyethylene & coatings to combat surgical trauma, friction, and others, are contributing to the faster adoption of femoral trials.

Improvements in surgical techniques and the development of real-time diagnostic imaging, such as computed tomography and magnetic resonance imaging, among others, have boosted the number of procedures performed. The global femoral trial market is increasingly inclined toward minimally invasive surgery owing to its lower footprint.

This trend has been encouraged by the advent of computer-assisted surgery and robotic surgery. Growth in the number of customizations based on the individual anatomy of a patient or in case of difficult reconstructive surgeries are also among factors driving the adoption of femoral trials.

However, the global femoral trial market is being hampered by the high cost of the procedure, risk of infection, implant failure, thrombosis, implant rejection, osteolysis, and lack of trained manpower & specialty hospitals.

Moreover, the average cost of surgery is approximately USD 50,000 in the U.S., however, there the prices vary largely in different states. The cost in Alabama is the lowest.

Access Full TOC of This Report @ https://www.persistencemarketresearch.com/toc/24079

Femoral trial Market: Segmentation

The global femoral trial market is segmented based on material of construction, cementing technique, sex, end users, and region.

Based on material of construction, the global femoral trial market is segmented into:

  • Metal Femoral Trial
    • Stainless Steel
    • Nickel titanium
    • Cobalt Chromium
    • Others
  • Polymer Femoral Trial
    • Polyethylene
    • Polycaprolactone
    • Others
  • Others

Based on cementing technique, the global patellar implant market is segmented into:

  • Cemented
  • Cement less

Based on sex, the global patellar implant market is segmented into:

  • Male
  • Female

Based on end users, the global patellar implant market is segmented into:

  • Hospitals
  • Clinics
  • Others

Market Trends: Overview

Metal hypersensitivity and toxicity, which affects about 10 to 15% of the population, is driving the femoral trial market toward the adoption of inert femoral trial materials such as polyethylene. The U.S. FDA in 2011 issued an advisory on metal implants, which necessitated clinical trials and postmarket studies for metal implants before they are released in the market.

Another trend is the increasing preference for high-density polyethylene that has a much lower rate of wear and porous metal technology. Porous metal technology is claimed to mimic the natural bone structure and result in lower rejection rates.

Newer materials such as ceramic are being tested. However, ceramic pieces are likely to break abruptly and lead to catastrophic failure, which occurs in about 2% of cases. Another issue with ceramics is that it causes an audible high-pitch squeaking noise during activity.

For In-Depth Competitive Analysis, Buy Now @  https://www.persistencemarketresearch.com/checkout/24079

More About the Report –

Unprecedented access to a world of information has given rise to the empowered, albeit distrustful, consumer. So is the case with healthcare, where the patient has been rendered more informed and conscientious thanks to the extraordinary penetration of the Internet. The discerning patient now demands more affordable, sophisticated, transparent, and personalized healthcare services, creating the need for new models for care.

The advent of health information technology (HIT) components such as electronic health records (EHR), hospital information systems (HIS), picture archiving and communication systems (PACS), and vendor-neutral archives (VNA) has had just as transformational an impact on the overall healthcare sector as the concerns regarding security and privacy. Data theft, undue access to personal health records, and cyber-attacks are very real threats that the healthcare sector faces today.

Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape

Molecular Diagnostics Market –

Molecular Diagnostics Market Segmentation by Key Players – Novartis AG, Roche Diagnostics, QIAGEN, Siemens Healthcare, Abbott Laboratories, Inc., Gen-Probe, Inc. (Hologic Inc.), Cepheid, Inc., Beckman Coulter, Inc., Becton, Dickinson & Company, Myriad Genetics, Inc., and bioMerieux.

Next-Generation Sequencing Market – 

Next Generation Sequencing Market Segmented by(By Application – Whole-genome Sequencing ,Exome Sequencing,Targeted Resequencing,De Novo Sequencing,RNA Sequencing,ChIP Sequencing,Methyl Sequencing,Others);By Technology- Targeted Sequencing & Resequencing,Whole Genome Sequencing,Whole Exome Sequencing.

Ophthalmology devises Market –

Ophthalmology devises Market Segmentation by Key Players – Abbott Medical Optics Inc., Carl Zeiss Meditec AG, Bausch & Lomb Inc., Essilor International S.A, Ziemer Ophthalmic Systems AG and Topcon Corporation.

Intravenous Iron Drugs Market – 

Intravenous (IV) Iron Drugs Market Segmentation by Key Players- Actavis, Inc., AMAG Pharmaceuticals, Inc., Galenica Ltd., Fresenius Medical Care AG & Co. KGaA, Vifor Pharma Ltd., American Regent, Inc., Luitpold Pharmaceuticals, Inc., Pharmacosmos A/S, Rockwell Medical Technologies, Inc., and Sanofi.

Syndromes Progressive Ataxia Weakness Disorders Market – 

Treatments for Syndromes of Progressive Ataxia and Weakness Disorders Market Segmentation by Key Players- Abbott Laboratories, Acorda Therapeutics Inc., American Regent Inc., Baxter International Inc., Biogen Idec., Bristol-Myers Squibb, Cadila Healthcare Ltd., Eli Lilly and Company, Glaxosmilthkline Plc., Sanofi, Roche Holding Ltd., Pfizer Inc. and Novartis AG.

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

305 Broadway, 7th Floor
New York City, NY 10007
United States
Ph.no. +1-646-568-7751
E-mail id- sales@persistencemarketresearch.com
Website: https://www.persistencemarketresearch.com

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl